Nephros Schedules Third Quarter 2024 Financial Results Conference Call
31. Oktober 2024 07:30 ET
|
Nephros, Inc.
SOUTH ORANGE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets,...
Nephros Launches New HydraGuard 20” UltraFilter
24. Oktober 2024 09:00 ET
|
Nephros, Inc.
New Filter Targets Additional Industries and Water Quality Compliance SOUTH ORANGE, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH) Nephros, Inc., a leader in advanced...
Nephros Schedules Second Quarter 2024 Financial Results Conference Call
01. August 2024 07:30 ET
|
Nephros, Inc.
SOUTH ORANGE, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today...
Nephros Announces Results for Quarter Ended September 30, 2023
08. November 2023 16:15 ET
|
Nephros, Inc.
Third-Quarter Net Revenue of $3.7 Million, a 55% Increase Over 2022; Net Loss from Continuing Operations Narrows 85% to $0.2 Million; $1.1 Million in Positive Year-to-Date Net Cash Flows from...
Nephros Announces Preliminary Results for First Quarter 2023
04. April 2023 07:30 ET
|
Nephros, Inc.
SOUTH ORANGE, NJ, April 04, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial...
Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022
11. Januar 2023 07:30 ET
|
Nephros, Inc.
Fourth Quarter Net Revenue of $2.6 Million; Full-Year Net Revenue of $10.0 Million;Active Customer Sites Continue to Climb SOUTH ORANGE, NJ, Jan. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –...
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
31. Januar 2020 07:30 ET
|
Nephros, Inc.
SOUTH ORANGE, NJ, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a commercial-stage company that develops and sells high performance...
Nephros Appoints Oliver Spandow to its Board of Directors
13. August 2018 07:30 ET
|
Nephros, Inc.
Seasoned Executive Adds Significant Operational and M&A Expertise SOUTH ORANGE, NJ, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device...
Nephros to Present at 8th Annual LD Micro Invitational
04. Juni 2018 07:45 ET
|
Nephros, Inc.
SOUTH ORANGE, NJ, June 04, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters...
Nephros Announces $2.9 Million Private Placement
11. April 2018 07:30 ET
|
Nephros, Inc.
SOUTH ORANGE, NJ, April 11, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters...